Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
APO-RANITIDNE ranitidine 300mg (as hydrochloride) tablet blister pack (Suspension from the ARTG under s.29D(1)(b))
Product name
APO-RANITIDNE ranitidine 300mg (as hydrochloride) tablet blister pack
Sponsor
ARTG
122014
Date action takes effect
Lapse date
Compliance action
Medicine suspension
Type of action
Suspension from the ARTG under s.29D(1)(b)
Grounds for regulatory action
Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable.
Suspension effective for 6 months. A decision was made to extend the suspension for a further 6 months in accordance with section 29E of the Act.